Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,774.00
Ask: 1,774.50
Change: -10.50 (-0.59%)
Spread: 0.50 (0.028%)
Open: 1,796.00
High: 1,808.50
Low: 1,772.50
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: FirstGroup Swings To Loss, CEO Departs

Thu, 31st May 2018 10:54

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------CRH, up 4.7%. The Irish building materials company said it will establish a new division effective from January 2019 that will bring together parts of its Europe and Americas business. The new Building Products division will combine the Europe Lightside, Europe Distribution and Americas Products divisions under the management of the latter's President Keith Haas. CRH also said it is targeting to improve its group earnings before interest, taxes, depreciation and amortisation margin by 300 basis points by 2021.----------Informa, up 2.2%. The events firm said it now expects its GBP3.90 million takeover of FTSE 250-listed rival UBM to become effective on June 15 after the UK Competition and Markets Authority announced it would not be investigating the acquisition. In China, Germany, Turkey and the US, the regulatory process was already completed.----------Mediclinic International, up 1.8%. Credit Suisse raised the private healthcare firm's price target to 660 pence from 630p, retaining its Neutral rating. Mediclinic is due to be demoted to the FTSE 250 in mid-June.----------FTSE 100 - LOSERS----------National Grid, down 3.9%. The electricity and utility company went ex-dividend, meaning that new buyers no longer qualify for the latest dividend payout. In addition, JPMorgan raised its price target to 950 pence from 870p, keeping its Overweight rating.----------GlaxoSmithKline, down 0.1%. JPMorgan re-initiated the pharmaceutical giant with a Neutral rating and price target of 1,500 pence.----------FTSE 250 - WINNERS----------B&M European Value Retail, up 3.4%. HSBC raised the discount retailer's price target to 500 pence from 470p, while retaining its Buy rating. On Wednesday, B&M reported a 25% jump in pretax profit for the year to the end of March to GBP229.3 million from GBP182.9 million the year before, on revenue that reached GBP2.98 billion, up 22% from GBP2.43 billion. B&M attributed the growth to its new store openings, with 47 new stores opened in the UK and 12 new stores opened in Germany. The 47 new stores in the UK contributed GBP128.4 million of revenue in the year alone. B&M now has 841 stores in the UK and 86 in Germany. ----------UBM, up 2.9%. The events firm's GBP3.90 million takeover by FTSE 100-listed rival Informa is to become effective on June 15 after the UK Competition and Markets Authority announced it would not be investigating the acquisition. In China, Germany, Turkey and the US, the regulatory process was already completed. UBM shares will cease trading on June 14.----------Electrocomponents up 2.2%. UBS raised the engineering firm's price target to 745 pence from 680p, retaining its Neutral rating.----------Ocado Group, up 1.1%. UBS upped its rating for the online grocer to Neutral from Sell and raised its price target to 750 pence from 280p, while JPMorgan raised its target price to 871p from 505p with a Neutral rating, following the news that Ocado will be promoted to the FTSE 100 Index.----------FTSE 250 - LOSERS----------FirstGroup, down 13%. The bus and train operator swung to a GBP326.9 million pretax loss for the year to the end of March, having reported a GBP152.6 million profit a year earlier due to Greyhound booking an impairment charge of GBP12.3 million on its property, plant and equipment. Moreover, FirstGroup also took a GBP260.6 million impairment of the carrying value of Greyhound goodwill, a GBP2.5 million impairment on the brand and trade name, and a GBP1.9 million impairment on software. This was on revenue of GBP6.4 billion, up 13% from GBP5.7 billion. In addition, Chief Executive Officer Tim O'Toole stepped down with immediate effect, with Non-Executive Chairman Wolfhart Hauser becoming executive chairman until a new CEO is found. FirstGroup said it has started the process to select a new CEO.----------Card Factory, down 3.3%. The greetings card retailer reported a 3% increase in group sales for the first quarter of 2018 despite a tough retail environment in the UK. However, like-for-like sales fell by 0.4%, and the online gifts retailer Getting Personal, acquired in 2011, continued to show a disappointing performance.----------Computacenter, down 2.2%. The computer services company went went ex-dividend, meaning that new buyers no longer qualify for the latest dividend payout.----------OTHER MAIN MARKET AND AIM - WINNERS----------Catanae Innovations, up 36%. The digital media and technology provider's joint venture Trust in Media Ltd signed its first agreement to provide its Fanbase service to an unnamed UK entertainment promoter.----------Cradle Arc, up 12%. The Africa-focused precious metals miner announced a maiden ore reserve estimate for its 60% owned open pit Mowana copper mine in Botswana, with proved and probable reserves at 31.8 million tonnes at 1.17% copper for 370,800 tonnes of contained copper metal.----------OTHER MAIN MARKET AND AIM - LOSERS----------Cluff Natural Resources, down 21%. The natural resources investing company said that the UK Oil and Gas Authority waived its requirement for a farm-out to be concluded by the end of May on Cluff's two wholly-owned North Sea gas licences P2248 and P2252. Cluff is currently looking for funding to support its aim of drilling at least one well on these licences.----------BlueRock Diamonds, down 15%. The diamond mining company raised GBP350,000 through a placing of 29.2 million shares at a price of 1.2 pence per share, which will go towards the development of the Kareevlei Diamond Mine in South Africa, which has an inferred grade of 6.3 carats per hundred tonnes.----------Akers Biosciences, down 14%. The rapid health technology manufacturer said that the NASDAQ stock market has given it a 180-day extension for the company to meet the minimum price rule for the US index of USD1.00 per share at the closing bid price of its common stock for 10 consecutive business days. In November, Akers was notified that it was not in compliance with with the bid price requirements for its stock.----------
More News
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 08:39

GSK raises $1.5 bln from sale of remaining Haleon stake

May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:33

FTSE 100 ends lower on disappointing corporate updates, BT Group soars

BT Group up after CEO aims for more than double free cash flow

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.